EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Characteristics, Antimicrobial Resistance Profile, and Risk Factors for Infection and Adverse Prognosis of Klebsiella pneumoniae Bloodstream Infection

Xuecan Zhu, He Tan, Chaoju Yang, Juntao Meng, Xiangsai Kong, Li Liu, Mengchuan Zhao, Pei Zhao, Qian Ma, Guojing Chai, Zhiqiang Han, Yongfeng Wang und 3 weitere

Antibiotics · 09.11.2026 · 15 (11) · 1118

DOI: 10.3390/antibiotics15111118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 09.11.2026. Verfasst von Xuecan Zhu und 14 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Medical Science Research Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Klebsiella pneumoniae bloodstream infection (KP-BSI) represents a global clinical threat, while local prognostic data are scarce in Hebei Province, China. This study aimed to identify risk factors for carbapenem-resistant Klebsiella pneumoniae (CRKP) infection and in-hospital mortality in KP-BSI patients.

Methods

A retrospective observational audit was conducted at a provincial tertiary hospital. Adult non-repeat KP-BSI episodes (2022–2025) were divided into CRKP (n = 156) and carbapenem-susceptible Klebsiella pneumoniae (CSKP, n = 357), as well as survivor and non-survivor subgroups. Clinical, laboratory and microbiological data were extracted from electronic medical records. Univariate and multivariate logistic regression analyses were performed.

Results

Among 513 KP-BSI cases, CRKP detection rate was 30.4% and the overall in-hospital mortality was 25.0%. CRKP isolates showed extensive multidrug resistance, with low resistance to colistin (3.5%) and tigecycline (49.0%). Advanced age (per 10-year increment), male sex, invasive procedures, empirical antimicrobial therapy and pre-existing respiratory disease were independent risk factors for CRKP infection. quick Pitt bacteremia score (qPitt score) ≥ 2 and intensive care unit (ICU) admission independently predicted in-hospital mortality; CRKP bacteremia was not an independent mortality predictor after confounder adjustment. Multisite KP isolation occurred in 44.4% of patients, most frequently from the respiratory tract.

Conclusions

CRKP-BSI imposes a considerable resistance burden. Infection control should target high-risk patients: elderly males with respiratory comorbidities undergoing invasive procedures. Mortality depends on disease severity (qPitt score, ICU admission), not carbapenem-resistance status. qPitt-based risk stratification and antimicrobial stewardship are essential to improve patient outcomes.

Förderung

  • Hebei Province Medical Science Research Project

Zitieren

APA

Zhu, X., Tan, H., Yang, C., Meng, J., Kong, X., Liu, L., Zhao, M., Zhao, P., Ma, Q., Chai, G., Han, Z., Wang, Y., Zhao, Y., Feng, Z., & Tie, Y. (2026). Clinical Characteristics, Antimicrobial Resistance Profile, and Risk Factors for Infection and Adverse Prognosis of Klebsiella pneumoniae Bloodstream Infection. Antibiotics, 15(11), 1118. https://doi.org/10.3390/antibiotics15111118

Vancouver

Zhu X, Tan H, Yang C, Meng J, Kong X, Liu L, et al. Clinical Characteristics, Antimicrobial Resistance Profile, and Risk Factors for Infection and Adverse Prognosis of Klebsiella pneumoniae Bloodstream Infection. Antibiotics. 2026;15(11):1118. doi:10.3390/antibiotics15111118

BibTeX
@article{Zhu2026,
  author = {Zhu, Xuecan and Tan, He and Yang, Chaoju and Meng, Juntao and Kong, Xiangsai and Liu, Li and Zhao, Mengchuan and Zhao, Pei and Ma, Qian and Chai, Guojing and Han, Zhiqiang and Wang, Yongfeng and Zhao, Yating and Feng, Zhishan and Tie, Yanqing},
  title = {Clinical Characteristics, Antimicrobial Resistance Profile, and Risk Factors for Infection and Adverse Prognosis of Klebsiella pneumoniae Bloodstream Infection},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1118},
  doi = {10.3390/antibiotics15111118}
}
Kostenlos starten →